Abnormal cerebral haemodynamics seem to be a significant cause of morbidity and mortality in newborn infants.1 However, our understanding of cerebral blood flow (CBF) in this age group remains relatively unsophisticated, and still relies heavily on data obtained from studies of animals or adults. This paper examines the merits and difficulties of methods available for measuring CBF in the newborn, and reviews some current concepts concerning perinatal cerebrovascular physiology.
Quantitative estimation of cerebral blood flow Most methods for CBF measurements in humans are based on the Fick principle, which states that the rate of accumulation of a tracer molecule in an organ (dQ/dt) is equal in the difference between the rate of delivery and the rate of removal of that tracer. The rate of delivery is the product of the blood flow to the organ (F) and the arterial concentration (Ca), and similarly the rate of removal is the product of blood flow and venous concentration (Cv).
Thus dQ/dt=(F-Ca)-(F Cv), and for the brain, by rearrangement: CBF= dQ (1) (Ca)-(Cv) dt As well as accumulation of tracer, the clearance of tracer (which is merely negative accumulation) can be used to measure flow. However, use of the Fick principle involves important assumptions: the substance must be neither consumed by, nor be produced in, the organ; the flow must be constant during the measurement period; and tracers must be either fully diffusible or completely non-diffusible.
THE 133xe CLEARANCE TECHNIQUE
This depends on the rate of clearance of an inert radioactive tracer from the brain. '33Xe is administered via either the carotid artery, the inspiratory gas, or a vein, in sufficient quantity to diffuse into the cells of the brain. As it is not metabolised, it can then only be removed from the brain by diffusing back into the blood, and the rate of clearance is proportional to CBF. The brain clearance (-dQ) can be detected by external scintillators placed over the skull and information on global or focal CBF is obtained.
Because the tracer is fully diffusible, Cv equals Q(t).X, where X is the blood-brain partition coefficient. As 90% of the 133Xe is cleared during each pass through the lungs, Ca is close to zero. Any significant recirculation of the tracer which makes Ca non-zero can be estimated from the activity in the expired air or by placing a detector over the chest, as alveolar gas is in equilibrium with pulmonary venous blood. A typical clearance curve is shown in fig
The 133Xe clearance technique can be performed in the neonatal unit and has allowed a considerable amount of data to be collected, but it involves exposure to ,, and , ionising radiation: using intravenous injection the mount of '33Xe in one CBF measurement MBq) results in a total body radiation dose of 0-2 mGy (20 mrad) which is similar to one to two chest x-ray examinations. Measurement also requires several minutes, so that rapid changes in CBF cannot be recorded.2
POSITRON EMISSION TOMOGRAPHY
Regional cerebral blood flow, together with glucose and oxygen consumption, can be observed using positron emission tomography (PET). H2150 is injected and emits positrons which collide with electrons in tissues, leading to annihilation of the particles and the emission of a pair of -y-ray photons at an angle of 1800 to each. Suitable detectors can determine the location of the annihilation event, and by comparing the clearance of the positron emitting isotope with the location of the annihilation events, determine regional CBF with a resolution of 3-4 mm.
The ability to measure regional blood flow is a great advantage. Unfortunately PET investigations are limited by the relatively high exposure to ionising radiation of 0-57 mGy (57 Cerebral blood flow and metabolism Absolute values of global CBF can be misleading as there is rapid and constant readjustment of regional blood flow to satisfy local metabolic requirements. Relatively low neuronal activity in the newborn brain means that metabolism can be maintained by a global CBF of 10 to 20 mV100O g/minute, about one third of the value
and is strongly affected by the byproducts of metabolism.
CBF is inversely related to the arterial oxygen content (CaO2) which is determined by the haemoglobin concentrations, the oxygen affinity of haemoglobin, and PaO2.24-26 The dissociation characteristics of oxygenated haemoglobin mean that changes in CaO2 have little effect on CBF until PaO2 falls below 5-6 kPa, but further falls occasion significant increases in CBF. One study also suggested that hyperoxia immediately after birth can lead to a prolonged reduction in CBF. 27 Hypoglycaemia is accompanied by a two-to threefold increase in CBF. [28] [29] [30] In case of the prolonged glucose restriction associated with placental dysfunction, cerebral hyperperfusion may persist for days after normoglycaemia has been established.31
The cerebral vessels are very sensitive to changes in PaCO2 as carbon dioxide readily passes the blood-brain barrier and alters the perivascular pH. Some byproducts of energy metabolism may effect the coupling between metabolic requirements and CBF. Adenosine has a strong vasodilator effect, and adenosine concentration in the brain increases during electrical stimulation or seizure activity. In the immediate vicinity of pial arterioles the potassium ion produces dose-related vasodilatation whereas local application of calcium causes vasoconstriction.41
Cerebral blood flow and arterial blood pressure Pressure autoregulation, defined as a constant CBF within a wide range of arterial blood pressures (the 'autoregulatory plateau'), is fully developed in fetal and neonatal animals.4243
Methodological and ethical constraints have prevented it from being appropriately investigated in newborn infants but preliminary results show that CBF remains constant during small and spontaneous changes in blood pressure. 34 In animals the autoregulatory plateau is not fixed but depends on the actual diameter of the vessels determined by other factors such as PaGO2 and GaO2. Pressure autoregulation becomes impaired when vasodilatation occurs during hypercapnia, hypoxia, hypoglycaemia or seizures, whereas vasoconstriction widens the autoregulatory plateau.44
The effect ofblood viscosity on cerebral blood flow The resistance to blood flow increases with higher haematocrit, and hence CBF tends to decrease. This fall, however, is partially caused by the concomitant rise in oxygen carrying capacity which is highly related to the haematocrit.45
This association between increased haematocrit and lower CBF has been well established in adults, and haematocrits greater than 0 7 lead to a significant risk of cerebral ischaemia. In the newborn infant blood viscosity is lower for a given haematocrit than in the adult, due to differences in both plasma components and red cell deformability. Data are not available to decide clearly on the upper limit for a safe haematocrit in the newborn infant, although many clinicians extrapolate from studies in adults for their everyday practice. When low CBF is coupled to a depressed cerebral function induced, for example, by sedatives or hypothermia, OER may remain normal, implying that CBF and GMRO2 are properly matched. However, OER will increase when CBF drops without a concomitant change in CMRO2, and this can be most easily observed as increasing desaturation in cerebral venous blood. In newborn dogs maximal OER occurs when the oxygen saturation of cerebral venous blood is about 0-4, and any further decline in oxygen delivery will lead to ischaemia.54 HIGH CEREBRAL BLOOD FLOW Hypoxia, hypercapnia, hypoglycaemia, and anaemia are associated with a rise in CBF which maintains normal CMRO2. However, in the hours following severe perinatal hypoxic-ischaemic injury a significant cerebral hyperperfusion has been observed which seems to be associated with reduced rather than increased CMRO2.12 55 56 The mechanism of this 'luxury perfusion' is unclear, although in fetal sheep it is mediated in part by NO production.57 The precise relation between delayed hyperperfusion following hypoxia-ischaemia and delayed impairments in cerebral energy metabolism is still unresolved, but in infants with birth asphyxia hyperperfusion is a sign of poor neurodevelopmental prognosis, particularly when accompanied by loss of pressure autoregulation and CO2 reactivity.55 Conclusion Studies of CBF have provided some insight into cerebrovascular physiology and pharmacology. However, the precise relation between CBF and cerebral damage remains elusive, and there is no definition of a threshold CBF below which ischaemic brain damage always occurs. Measurement of CBF thus does not currently provide a secure guide in the clinical management of sick infants. Further work, particularly using techniques like magnetic resonance imaging and NIRS, which provide data in addition to CBF measurements, may yet disclose strategies which manipulate CBF to reduce cerebral ischaemia. While cerebral injury remains a substantial problem in neonatal intensive care, such research is urgently needed.
